Literature DB >> 18407163

Molecular genetics of the ACTH and melanocyte-stimulating hormone receptors.

R D Cone1, K G Mountjoy.   

Abstract

The related ACTH and melanocyte-stimulating hormone (MSH) receptors control adrenal steroidogenesis and pigmentation in response to an overlapping set of peptides derived from the proopiomelanocortin (POMC) molecule. The recent cloning of these receptors has already opened up a new understanding of their role in normal and pathologic functioning of the adrenal cortex, and of the process of pigmentation. The murine MSH receptor maps to a genetic locus called extension, a locus known since early in this century to control the relative amounts of the two major types of melanins: eumelanin and phaeomelanin. The highly variable pigmentation phenotypes resulting from different extension locus alleles are caused by structural mutations in the MSH receptor that alter the degree of its signal-transducing capacity. A mutation in the ACTH receptor in a patient with ACTH resistance has also recently been reported. It is likely that the etiology of this rare disease includes mutations that affect the functioning of the ACTH receptor.

Entities:  

Year:  1993        PMID: 18407163     DOI: 10.1016/1043-2760(93)90129-3

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  4 in total

Review 1.  Participation of the central melanocortin system in metabolic regulation and energy homeostasis.

Authors:  Jin Kwon Jeong; Jae Geun Kim; Byung Ju Lee
Journal:  Cell Mol Life Sci       Date:  2014-06-04       Impact factor: 9.261

Review 2.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 3.  Family of melanocortin receptor (MCR) genes in mammals-mutations, polymorphisms and phenotypic effects.

Authors:  M Switonski; M Mankowska; S Salamon
Journal:  J Appl Genet       Date:  2013-08-31       Impact factor: 3.240

Review 4.  Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis.

Authors:  Rosa Maria Paragliola; Giampaolo Papi; Alfredo Pontecorvi; Salvatore Maria Corsello
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.